Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

Daniel D. Shapiro; Jose A. Karam; Viraj A. Master; Logan W. Zemp; Wade J. Sexton; Surena F. Matin; Philippe E. Spiess; E. Jason Abel

doi:10.1016/j.eururo.2023.04.023

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, Logan W. Zemp, Wade J. Sexton, Surena F. Matin, Philippe E. Spiess, E. Jason Abel

Urology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e55-e56
Journal	European urology
Volume	84
Issue number	2
DOIs	https://doi.org/10.1016/j.eururo.2023.04.023
State	Published - Aug 2023

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2023.04.023

Cite this

Shapiro, D. D., Karam, J. A., Master, V. A., Zemp, L. W., Sexton, W. J., Matin, S. F., Spiess, P. E., & Jason Abel, E. (2023). Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6. European urology, 84(2), e55-e56. https://doi.org/10.1016/j.eururo.2023.04.023

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6. / Shapiro, Daniel D.; Karam, Jose A.; Master, Viraj A. et al.
In: European urology, Vol. 84, No. 2, 08.2023, p. e55-e56.

Research output: Contribution to journal › Letter › peer-review

Shapiro, DD, Karam, JA, Master, VA, Zemp, LW, Sexton, WJ, Matin, SF, Spiess, PE & Jason Abel, E 2023, 'Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6', European urology, vol. 84, no. 2, pp. e55-e56. https://doi.org/10.1016/j.eururo.2023.04.023

Shapiro DD, Karam JA, Master VA, Zemp LW, Sexton WJ, Matin SF et al. Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6. European urology. 2023 Aug;84(2):e55-e56. doi: 10.1016/j.eururo.2023.04.023

Shapiro, Daniel D. ; Karam, Jose A. ; Master, Viraj A. et al. / Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re : Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6. In: European urology. 2023 ; Vol. 84, No. 2. pp. e55-e56.

@article{a9167bbd615642989c054569e4a58f7f,

title = "Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6",

author = "Shapiro, {Daniel D.} and Karam, {Jose A.} and Master, {Viraj A.} and Zemp, {Logan W.} and Sexton, {Wade J.} and Matin, {Surena F.} and Spiess, {Philippe E.} and {Jason Abel}, E.",

year = "2023",

month = aug,

doi = "10.1016/j.eururo.2023.04.023",

language = "English (US)",

volume = "84",

pages = "e55--e56",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re

T2 - Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

AU - Shapiro, Daniel D.

AU - Karam, Jose A.

AU - Master, Viraj A.

AU - Zemp, Logan W.

AU - Sexton, Wade J.

AU - Matin, Surena F.

AU - Spiess, Philippe E.

AU - Jason Abel, E.

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85164496080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85164496080&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2023.04.023

DO - 10.1016/j.eururo.2023.04.023

M3 - Letter

C2 - 37149462

AN - SCOPUS:85164496080

SN - 0302-2838

VL - 84

SP - e55-e56

JO - European urology

JF - European urology

IS - 2

ER -

Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43–6

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this